cromolyn sodium has been researched along with naproxen in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Al-Ghussein, MA; Bustanji, Y; El-Maraghy, S; Motawi, TM; Taha, MO | 1 |
| Al Ghussein, MA; Bustanji, Y; El-Maraghy, SA; Motawi, TM; Taha, MO | 1 |
4 other study(ies) available for cromolyn sodium and naproxen
| Article | Year |
|---|---|
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Evaluation of naproxen and cromolyn activities against cancer cells viability, proliferation, apoptosis, p53 and gene expression of survivin and caspase-3.
Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cromolyn Sodium; Dose-Response Relationship, Drug; Gene Expression; Humans; Inhibitor of Apoptosis Proteins; Naproxen; Real-Time Polymerase Chain Reaction; Survivin; Tumor Suppressor Protein p53 | 2014 |
Naproxen and cromolyn as new glycogen synthase kinase 3β inhibitors for amelioration of diabetes and obesity: an investigation by docking simulation and subsequent in vitro/in vivo biochemical evaluation.
Topics: Animals; Binding Sites; Cromolyn Sodium; Diabetes Mellitus; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Mice; Molecular Docking Simulation; Naproxen; Obesity; Protein Binding; Protein Conformation | 2013 |